Akebia news
「Akebia news」熱門搜尋資訊
![Akebia news](https://i0.wp.com/api.multiavatar.com/Akebia+news.png?apikey=viVnb6N20jclO8)
「Akebia news」文章包含有:「AKBA.O」、「AkebiaTherapeuticsCompletedTypeAMeetingwiththe...」、「AkebiaTherapeutics,Inc.(AKBA)StockPrice」、「AkebiaTherapeutics」、「AkebiaTherapeutics」、「PressReleases」
查看更多![AKBA.O](https://api.multiavatar.com/AKBA.O+-+Akebia+Therapeutics+Inc.png?apikey=viVnb6N20jclO8)
AKBA.O
https://www.reuters.com
Get Akebia Therapeutics Inc (AKBA.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
![Akebia Therapeutics Completed Type A Meeting with the ...](https://api.multiavatar.com/Akebia+Therapeutics+Completed+Type+A+Meeting+with+the+....png?apikey=viVnb6N20jclO8)
Akebia Therapeutics Completed Type A Meeting with the ...
https://www.prnewswire.com
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney ...
![Akebia Therapeutics, Inc. (AKBA) Stock Price](https://api.multiavatar.com/Akebia+Therapeutics%2C+Inc.+%28AKBA%29+Stock+Price%2C+News%2C+Quote+....png?apikey=viVnb6N20jclO8)
Akebia Therapeutics, Inc. (AKBA) Stock Price
https://finance.yahoo.com
Shares of Akebia Therapeutics (NASDAQ: AKBA) were up more than 10% Tuesday after rising to as high as 13.1% in early trading. The biopharmaceutical company, ...
![Akebia Therapeutics](https://api.multiavatar.com/Akebia+Therapeutics%3A+Home.png?apikey=viVnb6N20jclO8)
Akebia Therapeutics
https://akebia.com
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
![Akebia Therapeutics](https://api.multiavatar.com/Akebia+Therapeutics%3A+Investor+Relations.png?apikey=viVnb6N20jclO8)
Akebia Therapeutics
http://ir.akebia.com
The Investor Relations website contains information about Akebia Therapeutics's business for stockholders, potential investors, and financial analysts.
![Press Releases](https://api.multiavatar.com/Press+Releases.png?apikey=viVnb6N20jclO8)
Press Releases
https://ir.akebia.com
Akebia Therapeutics Announces Positive Top-Line Results of Phase 4 IMPACT Study of Auryxia® (ferric citrate) for In-Center and Home Dialysis Patients.